Corcept Therapeutics
CORT
#3417
Rank
S$5.15 B
Marketcap
S$48.45
Share price
-2.41%
Change (1 day)
-36.18%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of December 2025 : S$0.47 Billion

According to Corcept Therapeutics 's latest financial reports the company has S$0.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$0.47 B-8.3%
2024-12-31S$0.52 B7.14%
2023-12-31S$0.48 B-15.97%
2022-12-31S$0.57 B91.5%
2021-12-31S$0.30 B-48.17%
2020-12-31S$0.58 B56.7%
2019-12-31S$0.37 B31.71%
2018-12-31S$0.28 B137.98%
2017-12-31S$0.11 B59.13%
2016-12-31S$74.58 M30.41%
2015-12-31S$57.19 M78.52%
2014-12-31S$32.03 M-53.92%
2013-12-31S$69.52 M-38.89%
2012-12-31S$0.11 B121.64%
2011-12-31S$51.32 M62.13%
2010-12-31S$31.65 M-5.51%
2009-12-31S$33.5 M27.97%
2008-12-31S$26.18 M4.78%
2007-12-31S$24.98 M72.34%
2006-12-31S$14.49 M-70.05%
2005-12-31S$48.41 M-20.65%
2004-12-31S$61.01 M210.2%
2003-12-31S$19.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$25.90 B 5,301.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$14.86 B 2,999.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$17.51 B 3,553.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$9.36 B 1,852.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$18.76 B 3,813.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.75 B 2,767.91%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.33 B-30.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.11 B-75.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$2.01 B 319.35%๐Ÿ‡บ๐Ÿ‡ธ USA